The COMBINE project is part of the IMI AMR Accelerator. One of the scientific aims of COMBINE is to improve and standardize the pneumonia animal model used in AMR research and to develop improved tools to reliably translate results in animals into results in humans. This workshop addressed the need for standard protocols to ease […]
This workshop will explore combination therapy, from treatment to diagnostics. This will be a hands-on workshop with lectures and ample time for discussions. This workshop will be held online and the link will be sent to the participants few days prior to the workshop.
GARDP organises a live webinar that will feature presentations on the following topics: – The AMR Studio: a multidisciplinary podcast on antimicrobial resistance (Eva Garmendia) – Resources by the British Society for Antimicrobial Chemotherapy (David Jenkins) – Advancing antimicrobial research and development with open access tools and resources: REVIVE (Astrid Pentz-Murr) The presentations will be […]
More information here.
Download the webinar flyer and agenda in PDF format.
Time: November 6, 15:00 - 16:30 CEST Speakers: Radu Botgros, M.D., Senior Scientific Officer for the Office of Health Threats and Vaccines Strategy at the European Medicines Agency (EMA). AMR Accelerator’s COMBINE and ERA4TB projects are excited to invite you to an engaging and informative webinar that will introduce you to what regulatory agencies can offer drug and […]
Join us for an insightful webinar on leveraging machine learning (ML) to tackle the challenges of antibiotic drug discovery amidst rising antimicrobial resistance (AMR). Discover how we developed the AntiMicrobial-KG, a comprehensive knowledge graph of in-vitro antibacterial assay data, and used it to train ML models for identifying potential antimicrobial compounds. Learn how our optimised […]
Join us for an exclusive webinar featuring leading experts in antimicrobial development as they present success stories in research on novel antibiotics and innovative antibacterial approaches! You will learn: - The latest breakthroughs in tackling multidrug-resistant Gram-negative bacteria. - The development of endolysins—from concept to first-in-human trials. - Key scientific insights, successes, and challenges shaping […]
The cost of treating tuberculosis – the role of health economics in TB treatment development Join us for this webinar with health economics experts to examine TB's global cost burden to health systems and patients. The webinar will cover the range of costs associated with TB, how we measure these, and the role of health […]
Join us for a webinar featuring leading experts in antimicrobial drug development, who will share their expertise in developing hollow fiber systems for both tuberculosis and Gram-negative or Gram-positive pathogens. Several case studies will be presented on why, when, and how to effectively utilise hollow fiber assays and their application in in vitro pharmacokinetics and […]